Kidney Function Tests: eGFR, Creatinine, Cystatin C, uACR, and Urinalysis

Kidney function tests are most useful when they are interpreted together rather than as isolated numbers. A blood Creatinine Test supports an estimated glomerular filtration rate (eGFR), Cystatin C with eGFR can add a second filtration marker when creatinine may be misleading, the Albumin Random Urine Test with Creatinine provides the urine albumin-to-creatinine ratio (uACR), and a Urinalysis Complete Test can reveal protein, blood, cells, casts, crystals, glucose, and infection-related findings.

An abnormal result does not automatically mean chronic kidney disease (CKD). Kidney results need to be interpreted with symptoms, medical history, medications, hydration, prior results, blood pressure, diabetes status, and whether an abnormality persists. CKD is defined by abnormalities of kidney structure or function with health implications that are present for at least three months.¹

Part of the Ulta Lab Tests Knowledge Center

This Kidney Function Tests pillar is part of a broader educational framework for understanding laboratory testing. For the overall testing landscape, start with The Complete Guide to Lab Tests and Blood Work. For help interpreting flags, reference intervals, units, and trends, see How to Read and Understand Your Lab Results. For ordering, preparation, and specimen-collection concepts, see Direct-Access Lab Testing: How It Works and What to Expect.

Kidney results often overlap with other body systems. Related pillar guides include Diabetes and Prediabetes Blood Tests, Heart Health Blood Tests, Metabolic Health, Weight Loss, and GLP-1 Monitoring, Liver Function Tests, and CBC and Anemia Blood Tests, with Inflammation and Autoimmune Blood Tests for focused inflammatory or autoimmune questions.

Kidney Testing: Key Facts at a Glance

Measure	Main question	Important caution
Creatinine-based eGFR	How much blood are the kidneys estimated to filter?	eGFR is an estimate. Muscle mass, recent cooked meat, creatine supplements, strenuous exercise, some medications, and rapidly changing kidney function may affect creatinine-based estimates.
Cystatin C-based eGFR or combined creatinine-cystatin C eGFR	Would a second filtration marker improve confidence in the estimate?	Cystatin C has different non-kidney influences, including corticosteroid use and thyroid status. Combined eGFR may improve accuracy but is still an estimate.
uACR	Are the kidneys leaking albumin into urine?	Exercise, fever, infection, urinary or menstrual bleeding, and short-term changes in glucose or blood pressure may temporarily increase urine albumin.
Urinalysis and urine microscopy	Is there protein, blood, glucose, ketones, inflammation, cells, casts, crystals, or infection-related evidence?	A dipstick is a screening tool. Microscopy, culture, repeat testing, imaging, or clinical evaluation may be necessary to identify the cause.
Electrolytes and related chemistry	Are fluid, acid-base, electrolyte, or mineral patterns abnormal?	These results are not kidney-specific. Severe electrolyte abnormalities can require urgent medical evaluation.

What Do Kidney Function and CKD Tests Measure?

The kidneys continuously filter blood, remove waste products and excess water, regulate sodium and potassium, help maintain acid-base balance, influence blood pressure, support red-blood-cell production through erythropoietin, and participate in vitamin D activation and mineral balance. No routine laboratory test measures all of these functions at once.

A kidney evaluation therefore combines several kinds of information:

• Filtration: creatinine-based eGFR, cystatin C-based eGFR, or a combined creatinine-cystatin C estimate.
• Kidney damage: uACR, total urine protein, urine sediment findings, and other evidence when clinically appropriate.
• Urine findings: protein, blood, white blood cells, casts, crystals, glucose, ketones, and signs of infection.
• Regulatory effects: potassium, sodium, bicarbonate, calcium, phosphorus, and other chemistry results.
• Clinical context: blood pressure, diabetes, cardiovascular disease, medications, supplements, symptoms, imaging, and prior results.

CKD is classified by cause, glomerular filtration category, and albuminuria category. A persistent eGFR below 60 mL/min/1.73 m² or persistent evidence of kidney damage can support CKD classification. An eGFR of 60 or higher does not exclude CKD when other markers of kidney damage are present, and G1 or G2 filtration categories alone do not establish CKD without another marker of damage.¹

Blood Tests and Urine Tests Answer Different Questions

Blood tests primarily help estimate filtration and evaluate the chemical consequences of kidney dysfunction. Creatinine and Cystatin C are filtration markers. BUN, Sodium, Potassium, Chloride, Carbon Dioxide/Bicarbonate, Calcium, Phosphorus, Glucose, and Albumin can add context, but none of these alone proves the cause of kidney disease.

Urine testing looks for leakage and sediment abnormalities. The Albumin Random Urine Test with Creatinine calculates uACR and is a central marker of albuminuria. The Protein Total Random Urine Test with Creatinine estimates total urine protein relative to urine creatinine. A Urinalysis Complete Test and Urinalysis Microscopic Test can reveal findings that an eGFR cannot.

What Kidney Tests May Show - and What They Cannot Show by Themselves

What a well-chosen test set may reveal

• A lower-than-expected estimated filtration level.
• Albumin or other protein loss in urine.
• Blood, white blood cells, casts, crystals, or organisms in urine.
• Electrolyte, bicarbonate, mineral, glucose, or albumin abnormalities that need follow-up.
• Whether a pattern is persistent, improving, worsening, or stable when results are trended.
• Whether a second filtration marker changes confidence near an important clinical threshold.

What laboratory testing cannot determine on its own

• The exact cause of every abnormal result.
• Whether an obstruction, structural abnormality, mass, or kidney stone is present; imaging may be needed.
• Whether one isolated abnormality is chronic.
• Whether symptoms are safe to manage without an examination.
• The correct medication, dose, or treatment plan for an individual.
• True measured GFR with perfect precision; routine eGFR equations are estimates.

Broad testing is not automatically better. Large panels can create incidental findings and false alarms. The strongest approach is to define the clinical question first, then choose the smallest set of tests that can answer it.

Who May Need Kidney Testing?

Testing frequency and test selection should be individualized. Common reasons to discuss kidney testing with a clinician include:

• Diabetes, high blood pressure, cardiovascular disease, obesity, or a family history of kidney disease.
• Known CKD, a previous acute kidney injury, recurrent kidney stones, or structural urinary-tract disease.
• Older age together with other risk factors or a prior downward kidney-function trend.
• Use of medications that require kidney-based dosing or can affect kidney function or electrolytes.
• Autoimmune disease, systemic infection, cancer, plasma-cell disorders, or other conditions that can involve the kidneys.
• Foamy urine, visible blood in urine, swelling, major changes in urination, flank pain, or otherwise unexplained symptoms that may warrant clinical evaluation.

For diabetes, current American Diabetes Association guidance recommends at least annual assessment of uACR and eGFR in all people with type 2 diabetes and in people with type 1 diabetes of at least five years' duration, with more frequent monitoring when CKD is established or the clinical situation requires it.¹³

Kidney Function as a Cardiometabolic Health Signal

Kidney health is closely connected with cardiovascular and metabolic health. The kidneys help regulate blood pressure, fluid balance, electrolytes, and metabolic waste. At the same time, diabetes, hypertension, obesity, vascular disease, and other cardiometabolic conditions can place additional stress on the kidneys. This is why kidney results may provide an important whole-body signal even before a person develops obvious kidney symptoms.

The key is to keep the test categories clear. Creatinine/eGFR, uACR, Cystatin C, and Urinalysis are kidney-focused tests. Tests such as Hemoglobin A1c, Lipid Panel, and Apolipoprotein B do not directly measure kidney filtration or kidney damage; they provide cardiometabolic context that may help explain or stratify risk.

Common situations and a focused starting test set

Situation	Why kidney evaluation may matter	Tests commonly considered
Diabetes or prediabetes	Chronic hyperglycemia increases the risk of albuminuria and CKD.	Creatinine/eGFR, uACR, Hemoglobin A1c, and Glucose.
High blood pressure	Hypertension can contribute to kidney damage, and kidney disease can complicate blood-pressure control.	Creatinine/eGFR, uACR, and electrolytes such as Sodium and Potassium.
Foamy urine	Persistent foam can have benign causes but may also accompany albumin or protein in urine.	uACR, Urinalysis Complete, and when total protein is relevant, uPCR.
Blood in urine	Hematuria can arise from the kidney, urinary tract, infection, stone disease, or other causes.	Urinalysis Complete and Urinalysis Microscopic; a Urine Culture Test, imaging, or specialist evaluation may be appropriate depending on symptoms and persistence.
Swelling or edema	Swelling may occur with kidney, heart, liver, venous, medication, or other disorders and requires context.	Comprehensive Metabolic Panel, Creatinine/eGFR, uACR, Urinalysis, and clinical evaluation.
Autoimmune or systemic disease	Selected systemic disorders can involve the glomeruli, tubules, blood vessels, or interstitium.	Start with kidney-focused testing such as Creatinine/eGFR, uACR, and Urinalysis; targeted immune studies should be selected according to the suspected disease rather than ordered as broad screening.

Related cardiometabolic tests that provide context

The following tests may help characterize related diabetes, insulin-resistance, lipid, or inflammatory risk. They should not be described as direct kidney-function tests.

• Hemoglobin A1c - provides a longer-term view of glucose exposure and helps identify diabetes-related kidney risk.
• Glucose - provides current blood-sugar context.
• Insulin Test - may add insulin-resistance context when interpreted with glucose and other metabolic findings.
• Lipid Panel - evaluates standard lipid patterns relevant to cardiovascular risk.
• Apolipoprotein B Test - estimates atherogenic lipoprotein-particle burden and can add cardiovascular risk context.
• hs-CRP Test - provides high-sensitivity inflammation information used in selected cardiovascular risk discussions; it is nonspecific and does not identify the cause of inflammation.

For deeper context, see Diabetes and Prediabetes Blood Tests, Heart Health Blood Tests, Metabolic Health, Weight Loss, and GLP-1 Monitoring, and CBC and Anemia Blood Tests, with Inflammation and Autoimmune Blood Tests for focused inflammatory or autoimmune questions. When autoimmune or inflammatory disease is suspected, testing should be driven by the clinical pattern rather than by a large undirected panel.

A Tiered Approach to Kidney Testing

Use status	Typical components	When it may be useful
Common first-line	Creatinine/eGFR, uACR, Urinalysis; often BUN and electrolytes as part of general chemistry.	Risk-based screening, baseline assessment, or monitoring of common chronic conditions.
Confirmatory or risk-refining	Cystatin C with eGFR, combined creatinine-cystatin C eGFR, and repeat uACR.	When creatinine may be biased, a result is close to a decision threshold, or an unexpected abnormality requires confirmation.
Targeted	uPCR, urine microscopy, urine culture, mineral-bone tests, Creatine Kinase, or disease-directed studies.	When symptoms, urine findings, CKD stage, medication exposure, or a suspected cause supports the choice.
Specialist-directed	Creatinine Clearance, timed urine collection, stone-risk studies, imaging, genetic testing, measured GFR, or kidney biopsy.	When routine testing does not answer the clinical question or a specific kidney process is suspected.
Emerging / not broadly validated	Novel tubular-injury biomarkers and consumer kidney-wellness scores.	Research, specialty, or limited-use settings. These should not replace guideline-supported eGFR, uACR, and urinalysis.
Usually not appropriate as broad screening	Large immune, genetic, stone, or 24-hour urine panels without a defined indication.	These can produce incidental findings and are better selected after history, examination, and first-line testing.

The eGFR and uACR Risk Matrix: Filtration and Kidney Damage Together

Kidney risk is better understood when filtration and albuminuria are evaluated together. KDIGO classifies stable adult kidney status using GFR categories G1 through G5 and albuminuria categories A1 through A3. These categories support risk assessment; they are not a self-diagnosis tool. Cause, age, comorbidities, trajectory, urine sediment, and other findings still matter.¹

GFR category	eGFR (mL/min/1.73 m2)	General description
G1	≥90	Normal or high. Does not establish CKD without another marker of kidney damage.
G2	60-89	Mildly decreased. Does not establish CKD without another marker of kidney damage.
G3a	45-59	Mildly to moderately decreased.
G3b	30-44	Moderately to severely decreased.
G4	15-29	Severely decreased.
G5	<15	Kidney failure category; clinical assessment is essential.

Albuminuria category	uACR (mg/g)	General description
A1	<30	Normal to mildly increased.
A2	30-300	Moderately increased.
A3	>300	Severely increased.

Risk generally rises as eGFR falls and uACR rises. Albuminuria can identify increased kidney and cardiovascular risk even when eGFR remains in G1 or G2. Conversely, a reduced eGFR can carry risk even when uACR is in A1.

One Abnormal eGFR Does Not Automatically Establish CKD

A single low eGFR can occur with acute illness, dehydration, a medication effect, laboratory variation, or a temporary creatinine change. A single high uACR can occur after strenuous exercise, fever, infection, urinary bleeding, or short-term metabolic stress. Unexpected low eGFR, elevated uACR, or hematuria generally requires confirmation rather than an immediate assumption of chronic disease.²

The three-month CKD definition does not mean every concerning result should wait three months. A large new creatinine rise, severely abnormal electrolyte result, very low urine output, rapidly changing kidney function, or symptoms of acute illness may require prompt or urgent assessment.

Creatinine Versus Cystatin C: When Each Marker Helps

Creatinine is produced through muscle metabolism and is widely used to calculate eGFR. Because creatinine production varies, creatinine-based eGFR can be less reliable in people with unusually high or low muscle mass, limb loss, paralysis, severe malnutrition, bodybuilding, or rapidly changing physiology. Recent cooked meat, creatine supplements, intense exercise, and some medications can also alter serum creatinine without an equivalent change in true filtration.

Cystatin C is less directly tied to muscle mass and can help when creatinine may be biased or when additional precision may change a decision. It is not free of non-kidney influences; corticosteroids, thyroid abnormalities, and other factors can affect cystatin C. A combined creatinine-cystatin C eGFR often improves accuracy and may be useful near medication-dosing, referral, or other decision thresholds.⁵

Approach	Strength	Important limitation
Creatinine-based eGFR	Widely available and useful for routine trending.	May be biased by muscle mass, diet, creatine, exercise, and some medications.
Cystatin C-based eGFR	Provides a filtration estimate with different non-GFR influences.	Can be affected by corticosteroids, thyroid status, and other conditions.
Combined eGFR	Often improves precision when the two markers provide complementary information.	Requires both markers and remains an estimate rather than measured GFR.

Kidney Function Test Guide

The following tables organize kidney-related laboratory tests by purpose. Each named Ulta Lab Tests test or panel is linked to its current product page. Always review the current product page for specimen type, preparation, panel contents, and availability before ordering. A product page does not determine whether a test is medically appropriate for a specific person.

Filtration and urine-damage tests

Test and quick facts	What it shows and how it is used	Preparation, influences, and limitations
Creatinine Test Use status: Common first-line Blood	Measures serum creatinine and supports creatinine-based eGFR. Used for baseline evaluation, screening in at-risk people, trends, medication-dosing context, and monitoring.	Muscle mass, recent cooked meat, creatine supplements, strenuous exercise, hydration, acute illness, and some medications can affect interpretation. Follow current product instructions.
Albumin Random Urine Test with Creatinine Use status: Common first-line Spot urine; reports uACR	Quantifies urine albumin relative to urine creatinine. Important in diabetes and CKD risk assessment and monitoring.	Collection timing, strenuous exercise, fever, infection, urinary or menstrual bleeding, and short-term glucose or blood-pressure changes can affect the result. Confirmation is often appropriate after an unexpected elevation.
Cystatin C Test with eGFR Use status: Confirmatory / risk-refining Blood	Measures cystatin C and provides a cystatin C-based filtration estimate. Useful when creatinine may be biased or a second estimate could change a decision.	Corticosteroids, thyroid status, and other non-GFR factors may influence cystatin C.
Estimated Glomerular Filtration Rate with Creatinine and Cystatin C Use status: Confirmatory / risk-refining Blood	Uses both filtration markers to generate a combined eGFR. May be useful when greater precision is important or single-marker estimates disagree.	The result is still an estimate and can reflect non-GFR influences on either marker.
Protein Total Random Urine Test with Creatinine Use status: Targeted Spot urine; uPCR	Estimates total urine protein relative to urine creatinine. May add information when non-albumin protein is suspected or total protein requires monitoring.	uPCR and uACR are not interchangeable. Transient proteinuria and collection conditions matter.
Urinalysis Complete Test Use status: Common first-line / symptom-directed Urine	Surveys physical, chemical, and microscopic urine findings. May identify protein, blood, glucose, ketones, leukocyte esterase, nitrite, cells, casts, crystals, or bacteria.	Collection quality and processing time matter. Abnormal findings may need microscopy, culture, repeat testing, imaging, or clinical evaluation.
Urinalysis Microscopic Test Use status: Targeted Urine sediment	Examines red cells, white cells, epithelial cells, casts, crystals, and microorganisms.	Contamination and delayed processing can mislead. The sediment pattern rarely identifies a diagnosis by itself.
Creatinine Clearance Test Use status: Specialist-directed Timed urine plus blood	Estimates creatinine clearance from timed urine and serum creatinine when an equation may not answer the clinical question.	Incomplete or over-collected urine is a major error source. Measured creatinine clearance can overestimate true GFR.

Chemistry, electrolyte, and mineral tests

Test and quick facts	What it shows and how it is used	Preparation, influences, and limitations
Urea Nitrogen (BUN) Test Use status: Common chemistry Blood	Measures urea nitrogen, a waste product influenced by filtration and urea production. Usually interpreted with creatinine and the clinical picture.	Protein intake, gastrointestinal bleeding, catabolic illness, hydration, liver function, and medications can alter BUN independently of GFR.
Sodium Test Use status: Common electrolyte Blood	Helps assess water balance and neurologic risk. Kidney handling is one of many influences on sodium concentration.	Abnormal sodium may reflect intake, losses, hormones, medications, heart or liver disease, or kidney dysfunction. Severe abnormalities can be urgent.
Potassium Test Use status: Common electrolyte Blood	Evaluates an electrolyte essential to muscle and heart electrical activity. Kidney disease and many medications can raise or lower potassium.	Hemolysis and collection technique can falsely raise potassium. Marked abnormalities require prompt clinical review.
Chloride Test Use status: Common electrolyte Blood	Interpreted with sodium and bicarbonate to evaluate fluid and acid-base patterns.	Chloride changes are not kidney-specific and should be interpreted with the broader electrolyte pattern.
Carbon Dioxide Test Use status: Common chemistry / acid-base context Blood	On a routine chemistry panel, total carbon dioxide serves mainly as a bicarbonate surrogate and helps evaluate acid-base balance.	Respiratory conditions, gastrointestinal losses, medications, kidney disease, and sample handling can affect the result. When bicarbonate is abnormal, clinicians may calculate the anion gap from routine electrolytes to help classify selected acid-base disorders. The anion gap is a calculated interpretive tool, not a direct kidney-function measurement.
Calcium Test Use status: Common chemistry / targeted CKD context Blood	Supports mineral-balance evaluation. In CKD it may be interpreted with phosphorus, PTH, vitamin D, and albumin.	Total calcium is affected by albumin and pH and does not always reflect biologically active calcium.
Calcium Ionized Test Use status: Targeted Blood	Measures biologically active calcium and may clarify calcium status when protein binding or acid-base changes complicate total calcium.	Collection and rapid handling matter because changes in pH affect ionized calcium.
Phosphate (as Phosphorus) Test Use status: Targeted by stage and context Blood	Assesses phosphorus balance, which becomes increasingly relevant in advanced CKD and CKD-mineral and bone disorder.	Diet, timing, cellular shifts, hormones, and medications influence phosphorus.
PTH Intact Test Use status: Targeted Blood	Helps evaluate parathyroid response and CKD-related mineral-bone abnormalities when appropriate.	Interpret with calcium, phosphorus, vitamin D, kidney function, assay method, and treatment history rather than in isolation.
Vitamin D 25-Hydroxy Total Test Use status: Risk-based / targeted Blood	Assesses vitamin D status and may contribute to selected mineral-bone evaluations.	It is not a kidney-filtration test. Supplements, season, sun exposure, absorption, body composition, and assay method can influence the result.
Albumin Test Use status: General chemistry context Blood	Measures serum albumin. Low values may reflect urinary loss but also inflammation, liver disease, nutrition, other protein losses, or fluid status.	Serum albumin is not the same as urine albumin and is not a stand-alone kidney-function test.
Glucose Test Use status: Metabolic-risk context Blood	Helps evaluate glycemia, an important driver of kidney risk in diabetes.	It does not directly measure filtration or kidney damage. Timing relative to food, acute illness, stress, and medications can influence glucose.
Uric Acid Test Use status: Risk-based / targeted Blood	May support gout or stone evaluation and can rise with reduced kidney excretion.	A uric acid value alone does not diagnose CKD, gout, or a kidney stone. Diet, alcohol, cellular turnover, medications, and kidney handling affect it.
Creatine Kinase Total Test Use status: Symptom- or exposure-directed Blood	Assesses muscle injury when rhabdomyolysis is suspected. Severe muscle breakdown can contribute to acute kidney injury.	Strenuous exercise, trauma, injections, seizures, and medications can elevate CK. Dark urine with severe muscle pain or weakness can require urgent assessment.
Urine Culture Test Use status: Symptom-directed Urine	Looks for bacterial growth when urinary infection is suspected and may help guide antimicrobial selection.	Collection quality and prior antibiotics can affect results. A culture is not a routine CKD screening test.

Timed urine and kidney-stone tests

Test and quick facts	What it shows and how it is used	Preparation, influences, and limitations
Protein Total 24 Hour Urine Test with Creatinine Use status: Targeted	Estimates total daily protein loss and includes urine creatinine to help assess collection adequacy.	Missed or extra collections can invalidate the estimate. Follow exact timing and storage instructions.
Calcium 24 Hour Urine Test Use status: Stone / mineral evaluation	Measures daily urinary calcium in selected stone, parathyroid, or mineral evaluations.	Diet, sodium intake, supplements, medications, and collection completeness matter.
Uric Acid 24 Hour Urine Test Use status: Selected stone evaluation	Measures urinary uric acid over a timed collection to help characterize stone risk in appropriate cases.	Diet, medications, urine volume, and complete collection are important.
Oxalic Acid 24 Hour Urine Test Use status: Selected stone evaluation	Assesses urinary oxalate, an important contributor to calcium oxalate stone risk.	Diet, supplements, gastrointestinal disease, handling, and collection completeness can alter the result.
Stone Analysis Use status: Targeted	Identifies the composition of a passed or removed stone and can help guide prevention strategies.	Requires a recovered stone specimen. Composition alone does not explain every cause of recurrence.
StoneRisk Panel Use status: Specialist-directed / recurrent-stone evaluation	Uses timed urine measurements to characterize lithogenic and protective factors associated with recurrent stone risk.	Exact panel contents and collection requirements must be reviewed before testing.

How Clinicians Choose Kidney Tests by Purpose

The following is an educational framework, not a diagnostic or treatment algorithm.

Clinical question	Often-considered starting point	Possible next step when indicated
Risk-based CKD screening	Creatinine/eGFR plus uACR; Urinalysis and general chemistry when appropriate.	Repeat unexpected findings, review blood pressure and diabetes status, and consider Cystatin C when it may change interpretation.
Unexpected low eGFR	Review prior values, hydration, illness, medications, supplements, muscle factors, and recent exercise.	Repeat Creatinine/eGFR, add uACR/Urinalysis, or use combined eGFR when appropriate.
Albumin or protein on urine testing	Quantify with uACR; consider uPCR when total or non-albumin protein matters.	Confirm persistence, review the urine sediment, and evaluate diabetes, blood pressure, infection, or systemic disease as indicated.
Blood or inflammatory findings in urine	Repeat a properly collected Urinalysis and add microscopy when appropriate.	Urine Culture, imaging, urologic evaluation, or nephrologic evaluation depending on symptoms, persistence, and sediment pattern.
Known CKD monitoring	eGFR trajectory and uACR plus chemistry guided by stage, cause, medications, and complications.	Anemia, mineral-bone, acid-base, nutrition, or kidney-failure-risk evaluation as clinically indicated.
Possible kidney stone	Symptoms, examination, Urinalysis, selected blood tests, and imaging.	Stone Analysis and targeted timed urine evaluation after the acute event for recurrent or high-risk stone disease.

Individual Tests Versus Panels

An individual test can answer a focused question and reduce incidental findings. A panel can be efficient when several related measurements are needed. However, product names do not guarantee identical contents. Review every current product page before ordering, and do not assume that a metabolic panel includes uACR, urinalysis, or cystatin C.

Panel or option	Potential role	Important limitation
Basic Metabolic Panel Test	Commonly groups glucose, calcium, electrolytes, BUN, and creatinine for broad chemistry context.	Verify the current product contents. A BMP does not replace uACR or urinalysis.
Comprehensive Metabolic Panel Test - CMP	Adds liver-related enzymes and proteins to common metabolic chemistry and may be useful for a broader baseline.	It remains broader than kidney assessment and does not directly measure urine albumin. Follow the current fasting instructions on the product page.
Electrolyte Panel Test	Focuses on sodium, potassium, chloride, and carbon dioxide/bicarbonate.	It does not estimate filtration unless creatinine is ordered separately.
Renal Function Panel Test	May combine kidney-related chemistry, filtration, electrolytes, albumin, and phosphorus.	Verify the exact contents and specimen requirements. A renal panel may not include urine albumin or urinalysis.
Kidney Profile	Bundles selected kidney-focused blood and urine markers.	Review the current product composition rather than relying on the panel name alone.
Kidney Profile Test - Expanded	Provides broader kidney-related testing than a focused individual marker.	More testing is not automatically better. Confirm that each included marker answers the intended question.
KH-1 Kidney Function Panel	Offers another bundled kidney-testing option.	Panel contents can differ from other kidney profiles; do not treat them as interchangeable.

Kidney Test Name and Abbreviation Crosswalk

Term	Meaning	Do not confuse with
eGFR	Estimated glomerular filtration rate calculated from creatinine, cystatin C, or both.	Measured GFR or creatinine clearance.
uACR / ACR	Urine albumin-to-creatinine ratio.	Serum albumin or total urine protein.
uPCR / UPCR / PCR	Urine protein-to-creatinine ratio.	uACR or polymerase chain reaction.
UA	Urinalysis.	Urine albumin measurement alone.
Urine microscopy	Microscopic examination of urine sediment.	Dipstick-only urinalysis.
BUN	Blood urea nitrogen.	Creatinine or eGFR.
CO2 on a chemistry panel	Total carbon dioxide, used mainly as a bicarbonate surrogate.	Arterial or venous blood-gas measurement.

How to Prepare for Kidney Blood and Urine Tests

Preparation depends on the exact test or panel. Follow the current Ulta Lab Tests product instructions and any clinician directions. General considerations include:

• Hydration: maintain your usual hydration unless instructed otherwise. Do not intentionally overhydrate or dehydrate to influence the result.
• Exercise: strenuous exercise may raise creatinine, creatine kinase, and urine albumin. If the purpose is a stable baseline, ask whether intense exercise should be avoided before collection.
• Diet: recent cooked meat can temporarily increase creatinine. Fasting requirements depend on the full set of tests ordered.
• Supplements: creatine can complicate interpretation of serum creatinine. Disclose supplements rather than stopping them without guidance.
• Medications: do not stop prescribed medication just to obtain a different result. Provide an accurate medication list because some drugs alter kidney function, electrolytes, or creatinine handling.
• Urine collection: follow clean-catch and timing instructions carefully. For uACR, an early-morning specimen is often preferred when practical.
• Temporary illness: fever, urinary infection, vomiting, diarrhea, bleeding, or a major metabolic disturbance can change results and may alter when repeat testing is useful.
• Timed urine collection: exact start and stop times, complete collection, storage, and total volume are essential.

Medications, Supplements, and Exposures That Can Affect Kidney Testing

Medication and exposure effects should be interpreted using an individualized framework. Monitoring depends on the medication, dose, kidney function, age, comorbidities, concurrent drugs, symptoms, and the reason the medication is being used.

Medication, supplement, or exposure	Why it may matter	Kidney-related considerations
NSAIDs	Nonsteroidal anti-inflammatory drugs can reduce kidney blood flow in susceptible people and may contribute to acute kidney injury, fluid retention, or electrolyte changes.	A clinician may review Creatinine/eGFR, BUN, and Potassium depending on risk and duration. Do not use a fixed self-monitoring schedule in place of medical guidance.
Lithium	Long-term lithium therapy requires kidney and other safety monitoring as part of prescribed care.	Kidney monitoring may include Creatinine/eGFR and other tests selected by the prescriber. Medication-level and thyroid monitoring are separate clinical considerations.
Certain antibiotics and other potentially nephrotoxic drugs	Some medications can affect kidney function or require kidney-based dosing.	The appropriate tests and timing depend on the specific medication and clinical situation. Acute illness or intravenous therapy may require clinician-directed monitoring rather than direct-access testing.
Iodinated contrast	Kidney function may be relevant before selected contrast-enhanced imaging studies, particularly in higher-risk patients.	The radiology or clinical team determines whether a recent Creatinine/eGFR is needed and how to manage individual risk. Do not delay necessary imaging solely to self-order testing.
Creatine supplements	Creatine use can increase serum creatinine and complicate creatinine-based eGFR interpretation without necessarily representing an equivalent decline in filtration.	Disclose creatine use. In selected cases, Cystatin C with eGFR or combined eGFR may provide additional context.
Significant toxin or heavy-metal exposure	Some toxic exposures can damage the kidneys, but exposure testing should be driven by a credible exposure history rather than broad routine screening.	Kidney evaluation may include core blood and urine tests plus exposure-specific testing selected for the suspected agent. Occupational or acute toxic exposure may require specialized clinical or poison-control guidance.

Important: do not stop, start, or change a prescription medication based only on a self-directed kidney panel. When medication safety is the question, the prescriber needs to interpret kidney function alongside the medication, dose, indication, blood pressure, electrolytes, and other clinical factors. For kidney-safe medication guidance, see the NIDDK overview of medicines and kidney safety and the National Kidney Foundation information on contrast dye and kidney health.

How to Understand Kidney Test Results

Start with the reason the test was ordered, then interpret results in five layers:

1. Confirm the analyte, specimen, unit, and method. A urine ratio is not the same as a blood concentration, and a dipstick result is not the same as a quantitative measurement.
2. Use the correct reference interval or clinical decision threshold. Laboratory reference intervals and guideline-based decision thresholds serve different purposes.
3. Compare prior results. Direction and rate of change may be more informative than a single value.
4. Look for a coherent pattern. Pair eGFR with uACR and urine findings, then integrate electrolytes, blood pressure, diabetes status, medications, and symptoms.
5. Determine the appropriate response. Depending on severity and context, the next step may be confirmation, routine follow-up, medication review, imaging, specialist evaluation, or urgent care.

For a broader explanation of flags, units, reference intervals, decision thresholds, and trends, read How to Read and Understand Your Lab Results.

Reference intervals are not the same as kidney-risk categories

A laboratory may not flag every clinically meaningful uACR or eGFR category, and a flagged electrolyte can range from a minor variation to an urgent abnormality. Conversely, a result inside a reference interval does not rule out kidney disease if the trend, urine sediment, symptoms, or imaging are concerning. Always compare values using the same units and understand whether the report is displaying a population reference interval or a clinical decision threshold.

Fictional results walkthrough

Consider a fictional adult with an eGFR in the G2 category and a uACR in A2, with no acute symptoms. G2 alone does not establish CKD, but persistent A2 albuminuria can represent kidney damage. The correct interpretation is neither "kidney failure" nor "everything is normal." Collection conditions, blood pressure, diabetes status, prior results, and repeat urine testing all matter.

If a repeat uACR returns to A1 after a urinary infection resolves, the interpretation changes. If A2 albuminuria persists for at least three months, it can support CKD classification even when filtration remains in G2.

Now consider a different fictional adult with a sudden major rise in creatinine, sharply reduced urine output, vomiting, and weakness. The chronic CKD risk matrix is not the first priority. A rapidly changing pattern can represent an acute problem and requires prompt clinical evaluation.

When Not to Order More Kidney Tests on Your Own

• When severe symptoms or a markedly abnormal known result calls for urgent medical evaluation rather than another outpatient panel.
• When a recent clinician-directed test already answers the question and there is no reason to expect a meaningful change.
• When an emerging biomarker or large autoimmune, genetic, or stone panel has no defined indication.
• When a timed urine collection cannot be completed accurately.
• When the more appropriate next step is imaging, physical examination, medication review, or specialist evaluation.

More data are not automatically better. Unnecessary testing can create false alarms, duplicate work, and delay the evaluation that is actually needed.

When Repeat or Confirmatory Testing May Be Needed

Biological and analytical variation are normal. Unexpected low eGFR, elevated uACR, or hematuria often needs confirmation. Timing depends on the problem:

• Prompt repeat or clinical assessment: a large new change, acute illness, severe electrolyte abnormality, or possible acute kidney injury.
• Repeat after a temporary influence resolves: for example, urine albumin after fever, infection, urinary bleeding, or strenuous exercise when clinically appropriate.
• Chronicity confirmation: persistence for at least three months when CKD is being considered and no urgent issue supersedes the timeline.
• Alternative filtration marker: Cystatin C or combined eGFR when creatinine is likely biased or additional accuracy could change a decision.
• Escalation to another method: urine microscopy, imaging, timed urine, measured GFR, or biopsy when routine tests cannot answer the question.

Do not simply repeat a potentially dangerous result without seeking guidance. A care team may need to act first, review medications, confirm the specimen, obtain an electrocardiogram, order imaging, or provide treatment.

When Professional or Urgent Care May Be Needed

Contact a clinician promptly for a substantial unexpected change in kidney function, persistent blood or protein in urine, new swelling, declining urine output, or recurrent urinary symptoms. Seek urgent or emergency evaluation for warning signs such as:

• Very little or no urine, especially with illness or swelling.
• Shortness of breath, chest pain, fainting, severe weakness, confusion, or new palpitations.
• Severe vomiting or diarrhea with inability to keep fluids down.
• Fever with flank pain, vomiting, or severe illness.
• Dark urine with severe muscle pain or weakness after exertion, injury, heat exposure, or a medication change.
• A laboratory result that the reporting service or clinician identifies as critical.

This article cannot determine whether an individual symptom or result is an emergency. Use urgent clinical care when the situation may be acute rather than waiting for another self-directed test.

Kidney Stone Testing Is a Different Clinical Question

Kidney-stone evaluation is not the same as routine CKD screening. During an acute episode, a Urinalysis Complete Test may identify blood or infection-related findings, while selected blood tests can assess kidney function, electrolytes, Calcium, and Uric Acid. Imaging is often needed to locate a stone and determine whether there is obstruction.¹⁴

After a stone is passed or removed, Stone Analysis can identify composition. People with recurrent or high-risk stones may undergo targeted timed urine testing such as a StoneRisk Panel, Calcium 24 Hour Urine Test, Uric Acid 24 Hour Urine Test, or Oxalic Acid 24 Hour Urine Test when clinically appropriate.

Explore the Kidney Function and CKD Knowledge Center

• Chronic Kidney Disease: Stages, Causes, Symptoms, and Tests
• Kidney Health in Diabetes: Why eGFR and uACR Matter
• Metabolic Health, Weight Loss, and GLP-1 Monitoring
• Heart Health Blood Tests
• CBC and Anemia Blood Tests
• Inflammation and Autoimmune Blood Tests
• The Complete Guide to Lab Tests and Blood Work
• How to Read and Understand Your Lab Results
• Direct-Access Lab Testing: How It Works and What to Expect

How Ulta Lab Tests May Help

When direct-access laboratory testing is available and appropriate, Ulta Lab Tests lets patients review individual kidney tests and panels, preparation information, and current pricing online. Product availability, state eligibility, specimen requirements, panel contents, and collection instructions can change, so confirm the current product page before ordering.

Direct-access testing does not replace a clinician when symptoms, medication decisions, pregnancy, acute illness, critical laboratory findings, or abnormal results require individualized care. Start with a defined question, choose the tests that answer that question, and plan clinical follow-up when an abnormal result could require treatment or urgent interpretation.

Questions to Ask a Clinician About Kidney Results

• Is this result new, persistent, or part of a longer trend?
• Do I have both a filtration estimate and a urine albumin measurement?
• Could muscle mass, diet, exercise, illness, supplements, or medications affect the result?
• Would Cystatin C with eGFR or combined creatinine-cystatin C eGFR change a decision?
• Does an abnormal urine finding need confirmation, microscopy, culture, imaging, or specialist review?
• How soon should testing be repeated, and what symptoms should trigger urgent care?
• Do any medications need kidney-based dosing or electrolyte monitoring?
• What blood-pressure, diabetes, cardiovascular, metabolic, or lifestyle factors are most important for my kidney risk?

Frequently Asked Questions

What is the best test for kidney function?

There is no single best test for every purpose. Creatinine/eGFR estimates filtration, uACR measures albumin leakage, and Urinalysis evaluates urine chemistry and sediment. Cystatin C or combined eGFR can refine filtration estimates in selected situations.

Can you have kidney disease with a normal eGFR?

Yes. Persistent albuminuria, urine-sediment abnormalities, structural abnormalities, or other markers of kidney damage can meet CKD criteria even when eGFR is 60 or higher. G1 and G2 categories alone do not establish CKD without evidence of kidney damage.

Does one low eGFR mean CKD?

Not necessarily. CKD generally requires persistence for at least three months or other evidence of chronic kidney damage. A new low eGFR can reflect acute illness, dehydration, medication effects, creatinine influences, or laboratory variation and may require prompt evaluation rather than delayed routine repetition.

Why is uACR important?

The uACR estimates urine albumin loss and adds kidney and cardiovascular risk information independent of eGFR. It can identify kidney damage before filtration is substantially reduced. Because urine albumin varies, an unexpected elevation often needs confirmation.⁶

How should I prepare for a urine albumin measurement?

Follow the laboratory's exact instructions. An early-morning clean-catch specimen is often preferred when practical. Avoid intense exercise before testing when advised and disclose fever, infection, urinary bleeding, menstruation, or major short-term glucose or blood-pressure changes because these can temporarily affect urine albumin.

When does cystatin C add value?

Cystatin C can help when creatinine may be biased by unusual muscle mass or when a more precise estimate could change medication dosing, referral, or another clinical decision. A combined creatinine-cystatin C equation often improves precision, but cystatin C also has non-kidney influences.

Is a high BUN the same as kidney failure?

No. BUN is influenced by kidney filtration, but it also changes with hydration, protein intake, gastrointestinal bleeding, catabolic illness, liver function, and medications. It should be interpreted with creatinine/eGFR and the rest of the clinical picture.

Is urinalysis the same as uACR?

No. A Urinalysis Complete Test surveys multiple urine features. The uACR quantitatively compares urine albumin with urine creatinine and is designed to detect albuminuria. Depending on the question, both may be appropriate.

Does blood on a urine dipstick always mean red blood cells are present?

No. A dipstick blood reaction can reflect red blood cells, hemoglobin, or myoglobin. Urine microscopy and the clinical context can help distinguish possibilities. Menstrual contamination and collection quality also matter.

Do kidney blood tests require fasting?

Many individual kidney markers do not require fasting, but a broader panel or another test ordered at the same time may have different instructions. Always follow the current product page. The preparation needed for a Comprehensive Metabolic Panel, for example, may differ from a focused Creatinine Test.

Should I drink extra water before testing?

Do not deliberately overhydrate or dehydrate. Maintain your usual hydration unless a clinician or collection instruction says otherwise. Excess water can dilute urine, while dehydration can change both blood and urine results.

How often should kidney tests be repeated?

Frequency depends on risk, current eGFR and albuminuria category, cause, rate of change, medications, and symptoms. Many people with diabetes need at least annual eGFR and uACR assessment, while established CKD, medication monitoring, or a new abnormality may require more frequent testing. A clinician should determine the interval.

Can blood or urine tests diagnose a kidney stone?

Laboratory findings can support a stone evaluation, but imaging is often needed to locate a stone and assess obstruction. Fever, uncontrolled pain, persistent vomiting, a solitary kidney, pregnancy, or reduced urine output changes the urgency.

Can I calculate eGFR myself from creatinine?

Online calculators can illustrate an estimate, but the laboratory-reported result should be interpreted using the correct equation, age range, units, and clinical context. Pediatric equations differ, and stable-state eGFR equations are less reliable when kidney function is changing rapidly.

Can I improve a kidney result before retesting?

The goal is an accurate result, not a temporarily better number. Do not stop medications, change supplements, or manipulate hydration simply to influence the laboratory value. Follow collection instructions, disclose temporary influences, and address the underlying health question with a clinician.

Main Takeaways

• Creatinine/eGFR estimates filtration, uACR measures albumin leakage, and Urinalysis identifies a different set of urine abnormalities.
• Creatinine and cystatin C have different non-kidney influences. A combined estimate can add confidence when precision matters.
• CKD generally requires an abnormality that persists for at least three months or other evidence of chronic kidney damage.
• eGFR and uACR should be evaluated together because filtration and albuminuria are separate dimensions of kidney risk.
• Diabetes, hypertension, cardiovascular disease, and metabolic health are closely connected with kidney risk, but cardiometabolic tests are context tests rather than direct kidney-function measurements.
• Medication, supplement, and exposure history can substantially change kidney-result interpretation.
• A single abnormal result should be assessed for severity, symptoms, trend, temporary influences, and the need for confirmation.
• Product and panel names are not interchangeable. Verify the current specimen, contents, preparation, and intended use before ordering.
• Urgent symptoms or a critical laboratory result require clinical care rather than another self-directed panel.

Primary References

1. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease.
2. KDIGO 2024 Top 10 Takeaways: Evaluation of CKD.
3. NIDDK: Tests and Diagnosis for Chronic Kidney Disease.
4. NIDDK: Identify and Evaluate Patients with Chronic Kidney Disease.
5. NIDDK: Estimated GFR Calculators and Current Equations.
6. National Kidney Foundation: Urine Albumin-Creatinine Ratio (uACR).
7. National Kidney Foundation: Estimated Glomerular Filtration Rate (eGFR).
8. National Kidney Foundation: Cystatin C.
9. MedlinePlus: Creatinine Test.
10. MedlinePlus: BUN (Blood Urea Nitrogen).
11. MedlinePlus: Electrolyte Panel.
12. MedlinePlus Medical Encyclopedia: Urinalysis.
13. American Diabetes Association Standards of Care in Diabetes - 2026: Chronic Kidney Disease and Risk Management.
14. NIDDK: Diagnosis of Kidney Stones.
15. NIDDK: Keeping Kidneys Safe - Smart Choices about Medicines.
16. National Kidney Foundation: Contrast Dye and Your Kidneys.

Recommended Kidney Lab Tests and Panels

Kidney filtration and kidney-damage tests

• Creatinine Test
• Albumin Random Urine Test with Creatinine - uACR
• Cystatin C Test with eGFR
• Estimated Glomerular Filtration Rate with Creatinine and Cystatin C
• Protein Total Random Urine Test with Creatinine - uPCR
• Creatinine Clearance Test
• Protein Total 24 Hour Urine Test with Creatinine

Urinalysis and urinary-infection tests

• Urinalysis Complete Test
• Urinalysis Microscopic Test
• Urine Culture Test

Kidney-related blood chemistry and electrolyte tests

• Urea Nitrogen (BUN) Test
• Sodium Test
• Potassium Test
• Chloride Test
• Carbon Dioxide Test
• Calcium Test
• Calcium Ionized Test
• Phosphate (as Phosphorus) Test
• PTH Intact Test
• Vitamin D 25-Hydroxy Total Test
• Albumin Test
• Glucose Test
• Uric Acid Test
• Creatine Kinase Total Test

Kidney-stone testing

• StoneRisk Panel
• Stone Analysis
• Calcium 24 Hour Urine Test
• Uric Acid 24 Hour Urine Test
• Oxalic Acid 24 Hour Urine Test

Kidney and metabolic panels

• Electrolyte Panel Test
• Basic Metabolic Panel Test
• Comprehensive Metabolic Panel Test - CMP
• Renal Function Panel Test
• Kidney Profile
• Kidney Profile Test - Expanded
• KH-1 Kidney Function Panel

Related Kidney and Health Areas on Ulta Lab Tests

• All Kidney Tests - broad directory of kidney and urinary testing.
• Kidney Health - testing related to filtration, waste removal, fluid balance, and kidney health.
• Kidney Disease Testing - testing related to kidney damage, reduced filtration, and CKD monitoring.
• Renal Function - kidney-related blood and urine testing.
• Protein in Urine - albumin and total-protein urine testing.
• Blood in Urine - urinalysis and related testing for hematuria.
• Urinary Tract Infection - urinalysis and urine-culture testing for possible urinary infection.
• Diabetes with Chronic Kidney Disease - focused testing for kidney risk in diabetes.
• High Blood Pressure - testing related to hypertension, kidney function, and cardiometabolic risk.
• Gout and Uric Acid Testing - uric-acid testing relevant to gout and selected stone evaluations.

Editorial Disclosure, Authorship, and Medical Note

Ulta Lab Tests provides direct-access laboratory testing. Product links are included when they match the educational topic; purchasing a test is not a substitute for diagnosis, treatment, or urgent medical care.

Written by: John R. | Originally published: August 1, 2026 | Last updated: August 11, 2026

Medical note: This guide is educational. A clinician should select and interpret testing in the context of symptoms, diagnoses, medications, pregnancy status, nutrition, hydration, and prior results. Do not start, stop, or change a prescription based on this article or one laboratory result.